Go to the page content

Izračunajte svoj ITM

Metrički sustav Imperijalni sustav
Metrički sustav / Imperijalni sustav

Nije samo stvar volje, debljina je složena bolest

Gubljenje kilograma nije tako jednostavno. Savjet jedi manje i kreći se više nije dovoljan i često takvim pristupom dolazimo do neuspjeha i frustracija. Genetika, okoliš i drugi faktori igraju ulogu u razvoju debljine. Niste sami u ovome. Pogledajte kako drugi preuzimaju kontrolu nad svojim zdravljem.

Pogledajte više priča o debljini
verden-v1

+1 milijarda

Ljudi žive s debljinom širom svijeta, što naglašava složenost bolesti i hitnu potrebu za sveobuhvatnim djelovanjem.

40-70%

Rizik od razvoja debljine može se pripisati genetici, što naglašava da se ne radi samo o volji, već i o biološkim faktorima.

 

mand-v1

+200

Debljina je povezana s više od 200 zdravstvenih komplikacija.



 

measuring-tape-v1

<0,5 omjer

Za zdravije srce, vaš struk trebao bi biti manji od polovice vaše visine.

 

 

hjerte-v1

5%

Gubitak kilograma već od 5% tjelesne težine može poboljšati zdravlje srca i kvalitetu života.

 

 

vaegt-v1

2.9 x

Osobe koje žive s debljinom imaju 2,9 puta veću vjerojatnost da dostignu svoju ciljanju tjelesnu težinu u suradnji s medicinskim stručnjacima.

 

Podrška i alati

Pronađite povezane članke
Reference
  1. T-P-3166: A systematic review and evaluation of current evidence reveals 236 obesity-associated disorders 
  2. Lopez-Jimenez, F. et al. (2022) ‘Obesity and cardiovascular disease: Mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation’, European Journal of Preventive Cardiology, 29(17), pp. 2218–2237. doi:10.1093/eurjpc/zwac187.  
  3. Ashwell, M. (2011) ‘Charts based on body mass index and waist-to-height ratio to assess the health risks of Obesity: A Review’, The Open Obesity Journal, 3(1), pp. 78–84. doi:10.2174/1876823701103010078.  
  4. Powell-Wiley, T.M. et al. (2021) ‘Obesity and cardiovascular disease: A scientific statement from the American Heart Association’, Circulation, 143(21). doi:10.1161/cir.0000000000000973.  
  5. Lau DCW, Wharton S. Canadian Adult Obesity Clinical Practice Guidelines: The Science of Obesity. Available from: https://obesitycanada.ca/guidelines/science. 
  6. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024 Mar 16;403(10431):1027-1050. doi: 10.1016/S0140-6736(23)02750-2. 
  7.  Jackson Leach R, Powis J, Baur LA, Caterson ID, Dietz W, Logue J, Lobstein T. Clinical care for obesity: A preliminary survey of sixty-eight countries. Clin Obes. 2020 Apr;10(2):e12357. doi: 10.1111/cob.12357. Epub 2020 Mar 3. PMID: 32128994. 
  8. Waalen J. The genetics of human obesity. Transl Res. 2014 Oct;164(4):293-301. doi: 10.1016/j.trsl.2014.05.010.  
  9. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. Endocr Pract. 2016 Jul;22 Suppl 3:1-203. doi: 10.4158/EP161365 
  10. Griauzde DH, Turner CD, Othman A, Oshman L, Gabison J, Arizaca-Dileo PK, Walford E, Henderson J, Beckius D, Lee JM, Carter EW, Dallas C, Herrera-Theut K, Richardson CR, Kullgren JT, Piatt G, Heisler M, Kraftson A. A Primary Care-Based Weight Navigation Program. JAMA Netw Open. 2024 May 1;7(5):e2412192. doi: 10.1001/jamanetworkopen.2024.12192